Table of Content

1. Executive Summary
    1.1. Market Definition and Scope
    1.2. Market Segmentation
    1.3. Key Research Objectives
    1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global mHealth Market

4. Market Overview
    4.1. Market Segmentation
        4.1.1. Segment Definition
        4.1.2. Industry Evolution / Developments
    4.2. Overview
    4.3. Market Dynamics
        4.3.1. Drivers
        4.3.2. Restraints
        4.3.3. Opportunities
    4.4. Global mHealth Market Analysis and Forecasts, 2017-2031

5. Key Insights
    5.1. Pipeline Analysis
    5.2. COVID-19 Pandemic Impact on Industry

6. mHealth Market Analysis and Forecast, by Product
    6.1. Introduction and Definitions
    6.2. Key Findings/Developments
    6.3. Market Value Forecast, by Product, 2017–2031
        6.3.1. Connected Medical Devices
            6.3.1.1. Heart Rate Monitors
            6.3.1.2. Activity Monitors
            6.3.1.3. Electrocardiograph
            6.3.1.4. Fetal Monitoring
            6.3.1.5. Neuromonitoring
            6.3.1.6. Others
        6.3.2. mHealth Applications
            6.3.2.1. Fitness & Wellness
            6.3.2.2. Diabetes
            6.3.2.3. Cardiovascular Diseases
            6.3.2.4. Central Nervous System Diseases
            6.3.2.5. Respiratory Diseases
            6.3.2.6. Musculoskeletal Diseases
            6.3.2.7. Smoking Cessation
            6.3.2.8. Medication Adherence
            6.3.2.9. Others
        6.3.3. mHealth Services
    6.4. Market Attractiveness, by Product

7. Global mHealth Market Analysis and Forecast, by End-user
    7.1. Introduction and Definitions
    7.2. Key Findings/Developments
    7.3. Market Value Forecast, by End-user, 2017–2031
        7.3.1. B2B
            7.3.1.1. Patients
            7.3.1.2. Caregivers
        7.3.2. B2C
            7.3.2.1. Providers
            7.3.2.2. Payers
            7.3.2.3. Employers
            7.3.2.4. Others
    7.4. Market Attractiveness, by End-user

8. Global mHealth Market Analysis and Forecast, by Region
    8.1. Key Findings
    8.2. Market Value Forecast, by Region, 2017–2031
        8.2.1. North America
        8.2.2. Europe
        8.2.3. Asia Pacific
        8.2.4. Latin America
        8.2.5. Middle East & Africa
    8.3. Market Attractiveness, by Region

9. North America mHealth Market Analysis and Forecast
    9.1. Introduction
        9.1.1. Key Findings
    9.2. Market Value Forecast, by Product, 2017–2031
        9.2.1. Connected Medical Devices
            9.2.1.1. Heart Rate Monitors
            9.2.1.2. Activity Monitors
            9.2.1.3. Electrocardiograph
            9.2.1.4. Fetal Monitoring
            9.2.1.5. Neuromonitoring
            9.2.1.6. Others
        9.2.2. mHealth Applications
            9.2.2.1. Fitness & Wellness
            9.2.2.2. Diabetes
            9.2.2.3. Cardiovascular Diseases
            9.2.2.4. Central Nervous System Diseases
            9.2.2.5. Respiratory Diseases
            9.2.2.6. Musculoskeletal Diseases
            9.2.2.7. Smoking Cessation
            9.2.2.8. Medication Adherence
            9.2.2.9. Others
        9.2.3. mHealth Services
    9.3. Market Value Forecast, by End-user, 2017–2031
        9.3.1. B2B
            9.3.1.1. Patients
            9.3.1.2. Caregivers
        9.3.2. B2C
            9.3.2.1. Providers
            9.3.2.2. Payers
            9.3.2.3. Employers
            9.3.2.4. Others
    9.4. Market Value Forecast, by Country, 2017–2031
        9.4.1. U.S.
        9.4.2. Canada
    9.5. Market Attractiveness Analysis
        9.5.1. By Product
        9.5.2. By End-user
        9.5.3. By Country

10. Europe mHealth Market Analysis and Forecast
    10.1. Introduction
        10.1.1. Key Findings
    10.2. Market Value Forecast, by Product, 2017–2031
        10.2.1. Connected Medical Devices
            10.2.1.1. Heart Rate Monitors
            10.2.1.2. Activity Monitors
            10.2.1.3. Electrocardiograph
            10.2.1.4. Fetal Monitoring
            10.2.1.5. Neuromonitoring
            10.2.1.6. Others
        10.2.2. mHealth Applications
            10.2.2.1. Fitness & Wellness
            10.2.2.2. Diabetes
            10.2.2.3. Cardiovascular Diseases
            10.2.2.4. Central Nervous System Diseases
            10.2.2.5. Respiratory Diseases
            10.2.2.6. Musculoskeletal Diseases
            10.2.2.7. Smoking Cessation
            10.2.2.8. Medication Adherence
            10.2.2.9. Others
        10.2.3. mHealth Services
    10.3. Market Value Forecast, by End-user, 2017–2031
        10.3.1. B2B
            10.3.1.1. Patients
            10.3.1.2. Caregivers
        10.3.2. B2C
            10.3.2.1. Providers
            10.3.2.2. Payers
            10.3.2.3. Employers
            10.3.2.4. Others
    10.4. Market Value Forecast, by Country/Sub-region, 2017–2031
        10.4.1. Germany
        10.4.2. U.K.
        10.4.3. France
        10.4.4. Italy
        10.4.5. Spain
        10.4.6. Rest of Europe
    10.5. Market Attractiveness Analysis
        10.5.1. By Product
        10.5.2. By End-user
        10.5.3. By Country/Sub-region
11. Asia Pacific mHealth Market Analysis and Forecast
    11.1. Introduction
        11.1.1. Key Findings
    11.2. Market Value Forecast, by Product, 2017–2031
        11.2.1. Connected Medical Devices
            11.2.1.1. Heart Rate Monitors
            11.2.1.2. Activity Monitors
            11.2.1.3. Electrocardiograph
            11.2.1.4. Fetal Monitoring
            11.2.1.5. Neuromonitoring
            11.2.1.6. Others
        11.2.2. mHealth Applications
            11.2.2.1. Fitness & Wellness
            11.2.2.2. Diabetes
            11.2.2.3. Cardiovascular Diseases
            11.2.2.4. Central Nervous System Diseases
            11.2.2.5. Respiratory Diseases
            11.2.2.6. Musculoskeletal Diseases
            11.2.2.7. Smoking Cessation
            11.2.2.8. Medication Adherence
            11.2.2.9. Others
        11.2.3. mHealth Services
    11.3. Market Value Forecast, by End-user, 2017–2031
        11.3.1. B2B
            11.3.1.1. Patients
            11.3.1.2. Caregivers
        11.3.2. B2C
            11.3.2.1. Providers
            11.3.2.2. Payers
            11.3.2.3. Employers
            11.3.2.4. Others
    11.4. Market Value Forecast, by Country/Sub-region, 2017–2031
        11.4.1. China
        11.4.2. Japan
        11.4.3. India
        11.4.4. Australia & New Zealand
        11.4.5. Rest of Asia Pacific
    11.5. Market Attractiveness Analysis
        11.5.1. By Product
        11.5.2. By End-user
        11.5.3. By Country/Sub-region
12. Latin America mHealth Market Analysis and Forecast
    12.1. Introduction
        12.1.1. Key Findings
    12.2. Market Value Forecast, by Product, 2017–2031
        12.2.1. Connected Medical Devices
            12.2.1.1. Heart Rate Monitors
            12.2.1.2. Activity Monitors
            12.2.1.3. Electrocardiograph
            12.2.1.4. Fetal Monitoring
            12.2.1.5. Neuromonitoring
            12.2.1.6. Others
        12.2.2. mHealth Applications
            12.2.2.1. Fitness & Wellness
            12.2.2.2. Diabetes
            12.2.2.3. Cardiovascular Diseases
            12.2.2.4. Central Nervous System Diseases
            12.2.2.5. Respiratory Diseases
            12.2.2.6. Musculoskeletal Diseases
            12.2.2.7. Smoking Cessation
            12.2.2.8. Medication Adherence
            12.2.2.9. Others
        12.2.3. mHealth Services
    12.3. Market Value Forecast, by End-user, 2017–2031
        12.3.1. B2B
            12.3.1.1. Patients
            12.3.1.2. Caregivers
        12.3.2. B2C
            12.3.2.1. Providers
            12.3.2.2. Payers
            12.3.2.3. Employers
            12.3.2.4. Others
    12.4. Market Value Forecast, by Country/Sub-region, 2017–2031
        12.4.1. Brazil
        12.4.2. Mexico
        12.4.3. Rest of Latin America
    12.5. Market Attractiveness Analysis
        12.5.1. By Product
        12.5.2. By End-user
        12.5.3. By Country/Sub-region
13. Middle East & Africa mHealth Market Analysis and Forecast
    13.1. Introduction
        13.1.1. Key Findings
    13.2. Market Value Forecast, by Product, 2017–2031
        13.2.1. Connected Medical Devices
            13.2.1.1. Heart Rate Monitors
            13.2.1.2. Activity Monitors
            13.2.1.3. Electrocardiograph
            13.2.1.4. Fetal Monitoring
            13.2.1.5. Neuromonitoring
            13.2.1.6. Others
        13.2.2. mHealth Applications
            13.2.2.1. Fitness & Wellness
            13.2.2.2. Diabetes
            13.2.2.3. Cardiovascular Diseases
            13.2.2.4. Central Nervous System Diseases
            13.2.2.5. Respiratory Diseases
            13.2.2.6. Musculoskeletal Diseases
            13.2.2.7. Smoking Cessation
            13.2.2.8. Medication Adherence
            13.2.2.9. Others
        13.2.3. mHealth Services
    13.3. Market Value Forecast, by End-user, 2017–2031
        13.3.1. B2B
            13.3.1.1. Patients
            13.3.1.2. Caregivers
        13.3.2. B2C
            13.3.2.1. Providers
            13.3.2.2. Payers
            13.3.2.3. Employers
            13.3.2.4. Others
    13.4. Market Value Forecast, by Country/Sub-region, 2017–2031
        13.4.1. GCC Countries
        13.4.2. South Africa
        13.4.3. Rest of Middle East & Africa
    13.5. Market Attractiveness Analysis
        13.5.1. By Product
        13.5.2. By End-user
        13.5.3. By Country/Sub-region

14. Competition Landscape
    14.1. Market Player – Competition Matrix (By Tier and Size of Companies)
    14.2. Market Share Analysis, by Company (2022)
    14.3. Company Profiles
        14.3.1. Dexcom, Inc.
            14.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
            14.3.1.2. Product Portfolio
            14.3.1.3. Financial Overview
            14.3.1.4. SWOT Analysis
            14.3.1.5. Strategic Overview
        14.3.2. Apple, Inc.
            14.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
            14.3.2.2. Product Portfolio
            14.3.2.3. Financial Overview
            14.3.2.4. SWOT Analysis
            14.3.2.5. Strategic Overview
        14.3.3. FitBit, Inc.
            14.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
            14.3.3.2. Product Portfolio
            14.3.3.3. Financial Overview
            14.3.3.4. SWOT Analysis
            14.3.3.5. Strategic Overview
        14.3.4. Withings
            14.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
            14.3.4.2. Product Portfolio
            14.3.4.3. Financial Overview
            14.3.4.4. SWOT Analysis
            14.3.4.5. Strategic Overview
        14.3.5. Proteus Digital Health, Inc.
            14.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
            14.3.5.2. Product Portfolio
            14.3.5.3. Financial Overview
            14.3.5.4. SWOT Analysis
            14.3.5.5. Strategic Overview
        14.3.6. Omada Health, Inc.
            14.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
            14.3.6.2. Product Portfolio
            14.3.6.3. Financial Overview
            14.3.6.4. SWOT Analysis
            14.3.6.5. Strategic Overview
        14.3.7. Welldoc, Inc.
            14.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
            14.3.7.2. Product Portfolio
            14.3.7.3. Financial Overview
            14.3.7.4. SWOT Analysis
            14.3.7.5. Strategic Overview
        14.3.8. Teladoc Health, Inc.
            14.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
            14.3.8.2. Product Portfolio
            14.3.8.3. Financial Overview
            14.3.8.4. SWOT Analysis
            14.3.8.5. Strategic Overview
        14.3.9. Noom, Inc.
            14.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
            14.3.9.2. Product Portfolio
            14.3.9.3. Financial Overview
            14.3.9.4. SWOT Analysis
            14.3.9.5. Strategic Overview
        14.3.10. Propeller Health.
            14.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
            14.3.10.2. Product Portfolio
            14.3.10.3. Financial Overview
            14.3.10.4. SWOT Analysis
            14.3.10.5. Strategic Overview
        14.3.11. Canary Health
            14.3.11.1. Company Overview (HQ, Business Segments, Employee Strength)
            14.3.11.2. Product Portfolio
            14.3.11.3. Financial Overview
            14.3.11.4. SWOT Analysis
            14.3.11.5. Strategic Overview
        14.3.12. BiogeniQ Inc.
            14.3.12.1. Company Overview (HQ, Business Segments, Employee Strength)
            14.3.12.2. Product Portfolio
            14.3.12.3. Financial Overview
            14.3.12.4. SWOT Analysis
            14.3.12.5. Strategic Overview
        14.3.13. Glooko, Inc.
            14.3.13.1. Company Overview (HQ, Business Segments, Employee Strength)
            14.3.13.2. Product Portfolio
            14.3.13.3. Financial Overview
            14.3.13.4. SWOT Analysis
            14.3.13.5. Strategic Overview
        14.3.14. Firstbeat Technologies
            14.3.14.1. Company Overview (HQ, Business Segments, Employee Strength)
            14.3.14.2. Product Portfolio
            14.3.14.3. Financial Overview
            14.3.14.4. SWOT Analysis
            14.3.14.5. Strategic Overview
        14.3.15. BioTelemetry, Inc.
            14.3.15.1. Company Overview (HQ, Business Segments, Employee Strength)
            14.3.15.2. Product Portfolio
            14.3.15.3. Financial Overview
            14.3.15.4. SWOT Analysis
            14.3.15.5. Strategic Overview



List of Figures

List of Figures

Figure 01: Global mHealth Market Value (US$ Mn) Forecast, 2017–2031

Figure 02: Global mHealth Market Value Share, by Product, 2022

Figure 03: Global mHealth Market Value Share, by End-user, 2022

Figure 04: Global mHealth Market Value Share Analysis, by Product, 2022 and 2031

Figure 05: Global mHealth Market Attractiveness Analysis, by Product, 2023–2031

Figure 06: Global mHealth Market Value Share Analysis, by End-user, 2022 and 2031

Figure 07: Global mHealth Market Attractiveness Analysis, by End-user 2023–2031

Figure 08: Global mHealth Market Value Share Analysis, by Region, 2022 and 2031

Figure 09: Global mHealth Market Attractiveness Analysis, by Region, 2023–2031

Figure 10: North America mHealth Market Value (US$ Mn) Forecast, 2017–2031

Figure 11: North America mHealth Market Value Share Analysis, by Country, 2022 and 2031

Figure 12: North America mHealth Market Attractiveness Analysis, by Country, 2023–2031

Figure 13: North America mHealth Market Value Share Analysis, by Product, 2022 and 2031

Figure 14: North America mHealth Market Attractiveness Analysis, by Product, 2023–2031

Figure 15: North America mHealth Market Value Share Analysis, by End-user, 2022 and 2031

Figure 16: North America mHealth Market Attractiveness Analysis, by End-user 2023–2031

Figure 17: Europe mHealth Market Value (US$ Mn) Forecast, 2017–2031

Figure 18: Europe mHealth Market Value Share Analysis, by Country/Sub-region, 2022 and 2031

Figure 19: Europe mHealth Market Attractiveness Analysis, by Country/Sub-region, 2023–2031

Figure 20: Europe mHealth Market Value Share Analysis, by Product, 2022 and 2031

Figure 21: Europe America mHealth Market Attractiveness Analysis, by Product, 2023–2031

Figure 22: Europe mHealth Market Value Share Analysis, by End-user, 2022 and 2031

Figure 23: Europe mHealth Market Attractiveness Analysis, by End-user 2023–2031

Figure 24: Asia Pacific mHealth Market Value (US$ Mn) Forecast, 2017–2031

Figure 25: Asia Pacific mHealth Market Value Share Analysis, by Country/Sub-region, 2022 and 2031

Figure 26: Asia Pacific mHealth Market Attractiveness Analysis, by Country/Sub-region, 2023–2031

Figure 27: Asia Pacific mHealth Market Value Share Analysis, by Product, 2022 and 2031

Figure 28: Asia Pacific America mHealth Market Attractiveness Analysis, by Product, 2023–2031

Figure 29: Asia Pacific mHealth Market Value Share Analysis, by End-user, 2022 and 2031

Figure 30: Asia Pacific mHealth Market Attractiveness Analysis, by End-user 2023–2031

Figure 31: Latin America mHealth Market Value (US$ Mn) Forecast, 2017–2031

Figure 32: Latin America mHealth Market Value Share Analysis, by Country/Sub-region, 2022 and 2031

Figure 33: Latin America mHealth Market Attractiveness Analysis, by Country/Sub-region, 2023–2031

Figure 34: Latin America mHealth Market Value Share Analysis, by Product, 2022 and 2031

Figure 35: Latin America mHealth Market Attractiveness Analysis, by Product, 2023–2031

Figure 36: Middle East & Africa mHealth Market Value Share Analysis, by Country/Sub-region, 2022 and 2031

Figure 37: Middle East & Africa mHealth Market Attractiveness Analysis, by Country/Sub-region, 2023–2031

Figure 38: Middle East & Africa America mHealth Market Value Share Analysis, by Product, 2022 and 2031

Figure 39: Middle East & Africa America mHealth Market Attractiveness Analysis, by Product, 2023–2031

Figure 40: Middle East & Africa mHealth Market Value Share Analysis, by End-user, 2022 and 2031

Figure 41: Middle East & Africa mHealth Market Attractiveness Analysis, by End-user 2023–2031

Figure 42: Global mHealth Market Share Analysis, by Company (2022)

List of Tables

List of Tables

Table 01: Global mHealth Market Value (US$ Mn) Forecast, by Product, 2017–2031

Table 02: Global mHealth Market Value (US$ Mn) Forecast, by End-user, 2017–2031

Table 03: Global mHealth Market Value (US$ Mn) Forecast, by Region, 2017–2031

Table 04: North America mHealth Market Value (US$ Mn) Forecast, by Country, 2017–2031

Table 05: North America mHealth Market Value (US$ Mn) Forecast, by Product, 2017–2031

Table 06: North America mHealth Market Value (US$ Mn) Forecast, by End-user, 2017–2031

Table 07: Europe mHealth Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

Table 08: Europe mHealth Market Value (US$ Mn) Forecast, by Product, 2017–2031

Table 09: Europe mHealth Market Value (US$ Mn) Forecast, by End-user 2017–2031

Table 10: Asia Pacific mHealth Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

Table 11: Asia Pacific mHealth Market Value (US$ Mn) Forecast, by Product, 2017–2031

Table 12: Asia Pacific mHealth Market Value (US$ Mn) Forecast, by End-user, 2017–2031

Table 13: Latin America mHealth Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

Table 14: Latin America mHealth Market Value (US$ Mn) Forecast, by Product, 2017–2031

Table 15: Latin America mHealth Market Value (US$ Mn) Forecast, by End-user 2017–2031

Table 16: Middle East & Africa mHealth Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

Table 17: Middle East & Africa mHealth Market Value (US$ Mn) Forecast, by Product, 2017–2031

Table 18: Middle East & Africa mHealth Market Value (US$ Mn) Forecast, by End-user 2017–2031